Monocyte subsets in coronary artery disease and their associations with markers of inflammation and fibrinolysis

Atherosclerosis

Volumn 234, Issue 1, 2014, Pages 4-10

  Shantsila, Eduard ^a   Tapp, Luke D ^a   Wrigley, Benjamin J ^a   Pamukcu, Burak ^a   Apostolakis, Stavros ^a   Montoro García, Silvia ^a   Lip, Gregory Y H ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Coronary artery disease; Interleukin 6 receptor; Monocyte subsets; Monocytes

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTOXIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; PRASUGREL; VASCULOTROPIN RECEPTOR 1; BIOLOGICAL MARKER;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYSIS; FLOW CYTOMETRY; FUNCTIONAL STATUS; HUMAN; IN VITRO STUDY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SURFACE PROPERTY; BLOOD; CLASSIFICATION; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; MIDDLE AGED; PHYSIOLOGY;

BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; FIBRINOLYSIS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MONOCYTES;

EID: 84897943212     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.02.009     Document Type: Article

References (26)

1. Hristov M., Weber C. Differential role of monocyte subsets in atherosclerosis. Thromb Haemost 2011, 106:757-762.
2. Woollard K.J., Geissmann F. Monocytes in atherosclerosis: subsets and functions. Nat Rev Cardiol 2010, 7:77-86.
3. Shantsila E., Lip G.Y. Monocytes in acute coronary syndromes. Arterioscler Thromb Vasc Biol 2009, 29:1433-1438.
4. Maekawa Y., Anzai T., Yoshikawa T., et al. Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction: a possible role for left ventricular remodeling. JAm Coll Cardiol 2002, 39:241-246.
5. Nahrendorf M., Swirski F.K., Aikawa E., et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. JExp Med 2007, 204:3037-3047.
6. Dresske B., El Mokhtari N.E., Ungefroren H., et al. Multipotent cells of monocytic origin improve damaged heart function. Am J Transplant 2006, 6:947-958.
7. Shantsila E., Montoro-Garcia S., Tapp L.D., et al. Fibrinolytic status in acute coronary syndromes: evidence of differences in relation to clinical features and pathophysiological pathways. Thromb Haemost 2012, 108:32-40.
8. Geissmann F., Jung S., Littman D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003, 19:71-82.
9. Auffray C., Sieweke M.H., Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol 2009, 27:669-692.
10. Shantsila E., Lip G.Y. Monocyte diversity in myocardial infarction. JAm Coll Cardiol 2009, 54:139-142.
11. Cros J., Cagnard N., Woollard K., et al. Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 2010, 33:375-386.
12. Zawada A.M., Rogacev K.S., Rotter B., et al. SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset. Blood 2011, 118:e50-e61.
13. Wrigley B.J., Lip G.Y., Shantsila E. The role of monocytes and inflammation in the pathophysiology of heart failure. Eur J Heart Fail 2011, 13:1161-1171.
14. Tapp L.D., Shantsila E., Wrigley B.J., et al. The CD14++CD16+ monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction. JThromb Haemost 2012, 10:1231-1241.
15. Rogacev K.S., Seiler S., Zawada A.M., et al. CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease. Eur Heart J 2011, 32:84-92.
16. Shantsila E., Wrigley B., Tapp L., et al. Immunophenotypic characterization of human monocyte subsets: possible implications for cardiovascular disease pathophysiology. JThromb Haemost 2011, 9:1056-1066.
17. Ziegler-Heitbrock L., Ancuta P., Crowe S., et al. Nomenclature of monocytes and dendritic cells in blood. Blood 2010, 116:e74-e80.
18. Sarwar N., Butterworth A.S., Freitag D.F., et al. Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet 2012, 379:1205-1213.
19. Zernecke A., Shagdarsuren E., Weber C. Chemokines in atherosclerosis: an update. Arterioscler Thromb Vasc Biol 2008, 28:1897-1908.
20. Morimoto H., Takahashi M., Shiba Y., et al. Bone marrow-derived CXCR4+ cells mobilized by macrophage colony-stimulating factor participate in the reduction of infarct area and improvement of cardiac remodeling after myocardial infarction in mice. Am J Pathol 2007, 171:755-766.
21. Shiba Y., Takahashi M., Yoshioka T., et al. M-CSF accelerates neointimal formation in the early phase after vascular injury in mice: the critical role of the SDF-1-CXCR4 system. Arterioscler Thromb Vasc Biol 2007, 27:283-289.
22. Mehta N.N., Li M., William D., et al. The novel atherosclerosis locus at 10q11 regulates plasma CXCL12 levels. Eur Heart J 2011, 32:963-971.
23. Liehn E.A., Tuchscheerer N., Kanzler I., et al. Double-edged role of the CXCL12/CXCR4 axis in experimental myocardial infarction. JAm Coll Cardiol 2011, 58:2415-2423.
24. Shantsila E., Watson T., Lip G.Y. Endothelial progenitor cells in cardiovascular disorders. JAm Coll Cardiol 2007, 49:741-752.
25. Harraz M., Jiao C., Hanlon H.D., et al. CD34- blood-derived human endothelial cell progenitors. Stem Cells 2001, 19:304-312.
26. Rogacev K.S., Cremers B., Zawada A.M., et al. CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography. JAm Coll Cardiol 2012, 60:1512-1520.